Major Study Supports Same-Day COVID-19 and Flu Vaccination
TUESDAY, June 30, 2026 (HealthDay News) — One trip to the pharmacy may be all you need to protect yourself from COVID-19 and the flu this fall.
A new study — published today in the Annals of Internal Medicine — found that getting both vaccines at the same visit is no riskier than getting a flu shot alone.
A team led by Yan Xie of the VA St. Louis Health Care System and the Washington University School of Medicine analyzed health records from 2.5 million U.S. veterans, comparing more than 700,000 adults who received both vaccines on the same day with 1.8 million who received only a flu shot.
Researchers tracked participants for 90 days after vaccination, monitoring 46 potential adverse events ranging from less serious to life-threatening.
The results showed same-day vaccination did not increase the risk of serious side effects, including heart and blood clotting problems, neurological disorders and immune-related conditions.
The study was conducted using multiple updated COVID-19 vaccine formulations from the fall of 2022 to the summer of 2025.
The authors say their findings support the short-term safety of receiving both vaccines during the same visit and could help guide future vaccine recommendations.
More information
The U.S. Centers for Disease Control and Prevention has more on the COVID-19 and flu vaccines.
SOURCE: HealthDay TV, June 30, 2026
Related Articles
Search Allergy Articles
What to Know About Anaphylaxis: Symptoms, Triggers & Treatment
UV Light Effective Against Indoor Allergens, Study Says
Yes, This is the Worst Pollen Season Ever — Until Next Year
Holiday Tips To Keep Allergies and Asthma Under Control
Peanut Allergy Risk Higher If Older Sibs Eat Peanuts, Study Finds
Holiday Tips To Keep Allergies and Asthma Under Control
Monthly Injection Could Free People With Severe Asthma From Steroids
Vitamins Might Be Key To Asthma Control In Children, Adults
Asthma More Common Among Kids Whose Moms Have Eating Disorders
Wildfire Smoke Puts Millions At Risk Across Midwest, Northeast
Moderna’s mRNA Flu Vaccine Back Under FDA Review
New Vaccine Schedule Released By American College of Obstetricians & Gynecologists
New Flu Strain Weakened This Year’s Vaccine Protection, CDC Says
FDA Declines to Review Moderna’s mRNA Flu Vaccine Application
Moderna Starts Large Bird Flu Study Despite Earlier HHS Funding Loss
